FDA Import Refusal AEK-0109200-2/1/1 — Novartis Pharmaceuticals Canada Inc.
The FDA refused shipment AEK-0109200-2/1/1 from Novartis Pharmaceuticals Canada Inc. (Canada) on May 17, 2012. The refused product falls under Drugs and Biologics — ANTI-HYPERTENSIVE N.E.C.. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- May 17, 2012
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 62CDY99 ANTI-HYPERTENSIVE N.E.C.
- Charges
- 75